Detailed information for compound 1775153

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 546.574 | Formula: C28H30N6O6
  • H donors: 6 H acceptors: 7 LogP: 3.08 Rotable bonds: 11
    Rule of 5 violations (Lipinski): 3
  • SMILES: OC[C@H](C(C)(C)C)NC(=O)c1ccc(c(c1)C(=O)O)c1ccc(nc1C(=O)Nc1ccc2c(c1)[nH]c(n2)N)OC
  • InChi: 1S/C28H30N6O6/c1-28(2,3)21(13-35)33-24(36)14-5-7-16(18(11-14)26(38)39)17-8-10-22(40-4)34-23(17)25(37)30-15-6-9-19-20(12-15)32-27(29)31-19/h5-12,21,35H,13H2,1-4H3,(H,30,37)(H,33,36)(H,38,39)(H3,29,31,32)/t21-/m1/s1
  • InChiKey: GCOUBMRQKZVBLN-OAQYLSRUSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens coagulation factor IX Starlite/ChEMBL References
Homo sapiens coagulation factor VII (serum prothrombin conversion accelerator) Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Echinococcus granulosus glycoprotein Antigen 5 coagulation factor VII (serum prothrombin conversion accelerator) 466 aa 384 aa 23.7 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Echinococcus multilocularis alpha 1,6 mannosyl glycoprotein 2.0732 0.5 0.5
Loa Loa (eye worm) hypothetical protein 2.0732 0.5 0.5
Echinococcus granulosus alpha 16 mannosyl glycoprotein 2.0732 0.5 0.5
Schistosoma mansoni beta-12-n-acetylglucosaminyltransferase II 2.0732 0.5 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 0.013 uM Inhibition of human F9a using spectrozyme-factor 9a as substrate after 3 mins ChEMBL. 23927973
IC50 (binding) = 0.06 uM Inhibition of human F7a using D-Ile-Pro-Arg-AFC as substrate after 3 mins ChEMBL. 23927973
IC50 (binding) > 33 uM Inhibition of human tissue plasminogen activator using spectrozyme tissue plasminogen activator as substrate after 3 mins ChEMBL. 23927973
IC50 (binding) > 33 uM Inhibition of human urokinase using S-2444 as substrate after 3 mins ChEMBL. 23927973
IC50 (binding) > 33 uM Inhibition of human trypsin using chromozyme-TRY as substrate after 3 mins ChEMBL. 23927973
IC50 (binding) > 33 uM Inhibition of human thrombin using S-2238 as substrate after 3 mins ChEMBL. 23927973
IC50 (binding) > 33 uM Inhibition of human F11a using S-2366 as substrate after 3 mins ChEMBL. 23927973
IC50 (binding) > 33 uM Inhibition of human F10a using S-2222 as substrate after 3 mins ChEMBL. 23927973

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.